SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-23-021675
Filing Date
2023-08-02
Accepted
2023-08-02 17:10:16
Documents
7
Effectiveness Date
2023-08-02
Reference 429
333-262391

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tmbr20230718_s8.htm S-8 58380
2 EXHIBIT 4.11 AMENDMENT TO TIMBER PHARMACEUTICALS, INC. 2020 OMNIBUS EQUITY INCEN ex_549561.htm EX-4.11 12223
3 EXHIBIT 5.1 LEGAL OPINION OF LOWENSTEIN SANDLER ex_547393.htm EX-5.1 8464
4 EXHIBIT 23.1 CONSENT OF KPMG, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex_550110.htm EX-23.1 2491
5 107.1 ex_545187.htm EX-FILING FEES 15070
6 b01.jpg GRAPHIC 7932
7 b02.jpg GRAPHIC 8946
  Complete submission text file 0001437749-23-021675.txt   121348
Mailing Address 3 MOUNTAINVIEW ROAD, SUITE 100 WARREN NJ 07059
Business Address 3 MOUNTAINVIEW ROAD, SUITE 100 WARREN NJ 07059 (917) 697-3130
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273619 | Film No.: 231136891
SIC: 2834 Pharmaceutical Preparations